Catalyst Pharmaceuticals, Inc. (CPRX)
23.40
-1.01
(-4.14%)
USD |
NASDAQ |
Mar 12, 16:00
23.40
0.00 (0.00%)
After-Hours: 20:00
Catalyst Pharmaceuticals Total Liabilities (Quarterly) : 152.54M for Dec. 31, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Assertio Holdings, Inc. | 213.97M |
| Ionis Pharmaceuticals, Inc. | 3.035B |
| Karyopharm Therapeutics, Inc. | 410.38M |
| Krystal Biotech, Inc. | 114.23M |
| Replimune Group, Inc. | 123.05M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.107B |
| Shareholders Equity (Quarterly) | 954.27M |
| Debt to Equity Ratio | 0.0029 |
| Current Ratio | 6.076 |
| Net Debt Paydown Yield | 0.00% |